Grigory Bazhutin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Grigory Bazhutin has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Elena A. Tyumina
Perm Federal Research Center of the Ural Branch of the Russian Academy of Sciences, Perm, Russia
1 shared publication - Irina B. Ivshina
Perm State University; Institute of Ecology and Genetics of Microorganisms of the Ural Branch of the Russian Academy of Sciences – branch of the Perm Federal Research Center, Ural Branch of the Russian Academy of Sciences
1 shared publication - Maria Subbotina
Perm Federal Research Center Ural Branch Russian Academy of Sciences, 13a Lenin Street, 614990 Perm, Russia
1 shared publication - Maxim A. Polygalov
Institute of Ecology and Genetics of Microorganisms of the Ural Branch of the Russian Academy of Sciences, Perm Federal Research Center of the Ural Branch of the Russian Academy of Sciences, 13 Golev Str., 614081 Perm, Russia
1 shared publication - Semyon M. Tyan
Institute of Ecology and Genetics of Microorganisms of the Ural Branch of the Russian Academy of Sciences, Perm Federal Research Center of the Ural Branch of the Russian Academy of Sciences, 13 Golev Street., 614081 Perm, Russia
1 shared publication
Latest Publications
- Open Access
- 26 May 2022
- Published by MDPI AG in Microorganisms
- Vol. 10 (6) , 1101
Cellular Modifications of Rhodococci Exposed to Separate and Combined Effects of Pharmaceutical Pollutants
Actinomycetes of the genus Rhodococcus (class Actinomycetia) are dominant dwellers of biotopes with anthropogenic load. They serve as a natural system of primary response to xenobiotics in open ecosystems, initiate defensive responses in the presence of pollutants, and are regarded as ideal agents capable of transforming and degrading pharmaceuticals. Here, the ability of selected Rhodococcus strains to co-metabolize nonsteroidal anti-inflammatory drugs (ibuprofen, meloxicam, and naproxen) and information on the protective mechanisms of rhodococci against toxic effects of pharmaceuticals, individually or in a mixture, have been demonstrated. For the first time, R. ruber IEGM 439 provided complete decomposition of 100 mg/L meloxicam after seven days. It was shown that versatile cellular modifications occurring at the early development stages of nonspecific reactions of Rhodococcus spp. in response to separate and combined effects of the tested pharmaceuticals included changes in electrokinetic characteristics and catalase activity; transition from unicellular to multicellular life forms accompanied by pronounced morphological abnormalities; changes in the average size of vegetative cells and surface area-to-volume ratio; and the formation of linked cell assemblages. The obtained data are considered as adaptation mechanisms in rhodococci, and consequently their increased resistance to separate and combined effects of ibuprofen, meloxicam, and naproxen.
- 26 May 2022
- Published by MDPI AG in Microorganisms
- Vol. 10 (6) , 1101
Open AccessCellular Modifications of Rhodococci Exposed to Separate and Combined Effects of Pharmaceutical Pollutants
Actinomycetes of the genus Rhodococcus (class Actinomycetia) are dominant dwellers of biotopes with anthropogenic load. They serve as a natural system of primary response to xenobiotics in open ecosystems, initiate defensive responses in the presence of pollutants, and are regarded as ideal agents capable of transforming and degrading pharmaceuticals. Here, the ability of selected Rhodococcus strains to co-metabolize nonsteroidal anti-inflammatory drugs (ibuprofen, meloxicam, and naproxen) and information on the protective mechanisms of rhodococci against toxic effects of pharmaceuticals, individually or in a mixture, have been demonstrated. For the first time, R. ruber IEGM 439 provided complete decomposition of 100 mg/L meloxicam after seven days. It was shown that versatile cellular modifications occurring at the early development stages of nonspecific reactions of Rhodococcus spp. in response to separate and combined effects of the tested pharmaceuticals included changes in electrokinetic characteristics and catalase activity; transition from unicellular to multicellular life forms accompanied by pronounced morphological abnormalities; changes in the average size of vegetative cells and surface area-to-volume ratio; and the formation of linked cell assemblages. The obtained data are considered as adaptation mechanisms in rhodococci, and consequently their increased resistance to separate and combined effects of ibuprofen, meloxicam, and naproxen.